Owl monkey peripheral blood mononuclear cells were treated with phytohemagglutinin and expanded in interleukin 2 (IL-2)-containing medium. The cells were then exposed to Herpesvirus saimiri (HVS strain S295C)-infected owl monkey kidney monolayer cells. Four to 6 weeks later, the lymphocytes showed increased clumping and cell growth and the ability to grow in the absence of IL-2. Control lymphocyte cultures not exposed to HVS eventually died out at '=6-8 weeks, even in the presence of IL-2. Although infected lymphocytes grew 'continuously in the absence of IL-2, their growth was enhanced by addition of IL-2 to the cultures. Natural killer cell-like cytotoxicity and -interferon release were also enhanced by IL-2. All cultures were positive for HVS antigens, infectious centers, or DNA.' The reactivity of monoclonal antibodies to cell surface markers suggested that the resultant cell lines were comprised of activated T cells. The properties of the in vitro-transformed cells were similar to those of cells established from HVS-induced owl monkey tumors. Our results suggest that infection of T lymphocytes with HVS results in decreased dependence of T cells upon exogenous IL-2 for growth.
Herpesvirus saimiri (HVS) is a horizontally spread T-cell tropic herpesvirus of squirrel monkeys. As such, it is a member of a large group of primate lymphotropic herpesviruses, which includes the B-cell tropic Epstein-Barr virus (EBV) of man, the EBV-like viruses of Old World monkeys and apes, and the T-cell tropic viruses of New World monkeys (1). HVS is not pathogenic for squirrel monkeys but is potently oncogenic for several other species of New World monkeys and rabbits, where it produces fatal T-cell lymphomas and leukemias (2) (3) (4) (5) (6) (7) (8) . Although HVS readily produces T-cell lymphomas in New World primates, only one lymphoid cell line has been established by in vitro transformation (9) . It is not clear whether HVS-induced lymphomas involve a progression of events including proliferation and subsequent neoplastic changes or if a single virus-induced event results in lymphoma. However, as normal T cells require interleukin 2 (IL-2; T-cell growth factor) for growth, in this report we will use the term transformation to indicate the ability of T lymphocytes to grow continuously in the absence of added IL-2. The ability to transform cells reproducibly with HYS in vitro would provide an important tool in the study of the molecular biology of oncogenic transformation by this virus. Additionally, transformation would provide the means for generating autologous target cells for the study of potential cytotoxic T cells, which may control infection in vivo in a similar way that HLA-restricted cytotoxic T cells control EBV-positive B cells in humans (10) . Moreover, it may be possible to
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Previous attempts to transform lymphocytes by cocultivation with HVS producer lymphocytes or by exposure to cellfree HVS have, with the rare exception noted above, been unsuccessful (refs. 3 and 13; unpublished results). Recently, cell lines were established with the aid of IL-2 from owl monkeys bearing HVS-induced tumors (14, 15) . These cell lines are not dependent on IL-2 for growth and survival as are normal T cells but respond to it strongly in terms of increased cell growth. Based on this observation and the failure of previous in vitro transformation attempts made without IL-2, it was reasonable to assume that HVS transformation in vitro might also be aided by IL-2. Therefore, a transformation protocol was established in which cells were first activated by phytohemagglutinin (PHA) to induce IL-2 receptors and then were expanded in IL-2-containing medium prior to exposure to virus. The cells were then exposed to HVS and further cultured in IL-2-containing medium prior to 'testing them for IL-2-independent growth, the criterion used for transformation. In this paper we report the establishment and characterization of a series of cell lines established in vitro by HVS transformation of owl monkey lymphocytes. A preliminary account of these results has been reported (16 (15) by using a FACS IV fluorescence-activated cell sorter (Becton Dickinson FACS Systems, Sunnyvale, CA). Assays for HVS-Intracellular and Membrane Antigens. Intracellular viral antigens were'detected by indirect immunofluorescence of acetone-fixed cells with well-characterized owl' monkey sera and fluorescein isothiocyanate-labeled goat anti-human IgG (Tago) essentially as described (22) . For detection of HVS-membrane antigen, indirect immunofluorescence staining was performed on viable cells (23) . Induction of membrane antigens was accomplished by treatment of the cells with 20 ng of phorbol 12-O-tetradecanoate 13-acetate (TPA)/ml and 0.5 mM n-butyrate for 3 days as described (24) .
Assays for Interferon (IFN). IFN was measured by the inhibition of the cytopathic effect of vesicular stomatis virus in WISH and MDBK cells, as described (25) . IFN titers were expressed in international units standardized with National Institutes of Health reference IFN-a, G-0234-901-527.
Assays for Cellular Cytotoxicity. A 51Cr-release assay was performed as described (26) . Target cells, MOLT 4 and K562, were labeled with 150 ACi (1 Ci = 37 GBq) of Na51CrO4 (New England Nuclear) for 30-45 min at 370C. The cells were then washed and resuspended at the desired concentration in RPMI 1640 medium containing fetal bovine serum. Effector cells were washed, enumerated, resuspended, and mixed at various effector-cell-to-target-cell ratios with target cells at 5 x 103 cells per reaction. Incubation was performed for 4 hr at 370C in 96-well round-bottom microtiter plates. Supernatants were then taken for determination of isotope release. Unlabeled target cells were added to labeled target cells as autologous controls. All experiments were done in triplicate. The percentage of isotope released was determined from the formula: %1 i experimental cpm -autologous cpm x 100. total cpm incorporated RESULTS Cell Transformation. PBL of five individual owl monkeys were separated, treated with PHA, expanded in IL-2, exposed to HVS, and cultured on IL-2-containing medium as described. After 4-6 wk of incubation, cells in the HVS-exposed cultures showed increased growth and, in four out of five cultures, also showed increased cell clumping compared to the cells in the non-HVS-exposed controls as determined by microscopic examination. At this time, cells of the virusexposed cultures were tested and found to be able to grow in the absence of added IL-2. Parallel cultures of each cell line, one set maintained in the presence of IL-2 and the other in its absence, were established for each line shortly after determining the ability of the cells to grow in the absence of added IL-2.
Cells of all infected lines grew in the absence of added IL-2 but grew much better in the presence of IL-2. This is illustrated in Fig. 1 for one representative cell line, 190(HVS). Cells, which had been growing without added IL-2, were seeded at 5 x 105 cells per ml in flasks of 25-cm2 surface area in 8 ml of medium that either contained or lacked IL-2. The cells were counted in a hemocytometer and reseeded at 5 x 105 cells per ml at 3-to 4-day intervals. The cumulative net cell increase was calculated from the individual cell counts. Fig. 1 shows that while the cells grew in the absence of IL-2, they achieved an approximately 2.5-fold greater increase in the presence of IL-2. In a separate experiment, it was shown that highly purified IL-2 at 300 units/ml (27) would enhance the growth of HVS-transformed cells (data not shown), suggesting that IL-2 was responsible for the increase in cell proliferation. Cells of four of the original lines were growing, with or without added IL-2, at >10 mo after exposure to HVS. The fifth cell line, 15(HVS), was lost to microbial contamination at 3 mo after virus exposure. Four of the non-HVS-exposed cultures gradually died out between 1.5 and 2 mo after initiation, even in the continued presence of IL-2. The fifth line, 224(PHA), grew better than the other control lines but was lost to microbial contamination at 4 mo. This cell line had been tested at 10 wk and was found to be dependent on IL-2 for growth.
The HVS-exposed cells grown either with or without IL-2 were morphologically distinguishable from non-virus-exposed IL-2-dependent cells. Fig. 2 shows a comparison of cells from transformed line 8(HVS) with IL-2-dependent control cells of the same donor. The HVS-exposed cells (Fig. 2 Left) appear larger, more heterogeneous in size and shape, and tend to have more cytoplasm than the non-HVSexposed control cells (Fig. 2 Right) . Their ed for virus-associated intracellular antigens by indirect immunofluorescence of acetone-fixed cells. Cells were tested after growth in the absence of IL-2 and after 3 days of growth in the presence of IL-2. Tests with a serum positive for both virus capsid antigen and early antigen showed that four of the five lines were positive for HVS intracellular antigens at levels between <1% and >6% of the cells scored. There was no obvious difference between cells grown on or off IL-2. Most of the antigen appeared to be early antigen, as staining with a virus capsid antigen-positive but early antigen-negative serum failed to stain cells of any of the lines except for 190(HVS), where a few (<1%) of the cells were positive (Table 1).
At 3 mo after initial exposure to virus, the cells were tested for IC on Vero cell monolayers. The results showed that lines 8(HVS) and 190(HVS) were high in IC, line 224(HVS) had a moderate level, while line 265(HVS) was low ( Table 1) . Cocultivation was repeated 3 mo later with essentially the same results.
At 5.5 mo after initial exposure to virus, the cell lines were tested for the presence of HVS membrane antigen ( Table 1) . Three of the four cell lines were positive, while line 265(HVS) was negative. The cell lines were also treated with 20 ng of TPA per ml and 0.5 mM n-butyrate for 3 days to determine if membrane antigen levels could be boosted. The results indicated that all lines, except for 265(HVS), showed increased levels of membrane antigen after TPA and butyrate treatment.
Analysis of Viral DNA in Cell Lines. Total cell DNA was prepared from cell lines 224(HVS) and 265(HVS). Southern blot hybridizations were used to determine approximate viral genome copy number and to obtain information on the nature of the viral DNA (Fig. 3) . By comparison to known amounts of virion DNA electrophoresed in parallel slots, we estimated that viral DNA represented about 0.06% of total DNA from 265(HVS) cells and about 1.0% of total DNA from 224(HVS) cells after 6 mo in culture. If one assumes the cellular diploid genome to be 6 x 106 kilobase pairs, cell lines 265(HVS) and 224(HVS) contained -24 and 400 genome copies per cell, respectively. The restriction endonuclease fragmentation patterns of viral DNA in the 224(HVS) cell line were the same as the parental virion DNA (Fig. 3 and other restriction endonuclease fragmentation patterns not shown). Since restriction endonuclease fragmentation patterns of different HVS strains are distinctive (28) , this verified that the 224(HVS) cell line contained the appropriate viral DNA. Also, this indicated that gross rearrangements and/or deletions were not prevalent in this cell line at this time. Circularization of viral DNA would not have been de- tected by these procedures because of the highly repetitive DNA at the termini of virion DNA. The EcoRI G and H fragments were highly underrepresented, however, in the 265(HVS) cell line. This was clearly evident upon long film exposure (Fig. 3B) . The results indicated that sequences contained within these fragments were deleted in most viral DNA molecules in the 265(HVS) cell line. This region of viral DNA has been found to be deleted in some tumor cell lines (19, 29) .
Cell Surface Phenotypes. At 2-2.5 mo after virus exposure, the transformed cell lines were tested with a series of MAb to human lymphocyte surface antigens that cross-react with owl monkey lymphocytes (15) . All four lines tested showed the same staining pattern, reacting with OKT1la, anti-Leu 5, and HLA DR. The cells uniformly failed to react with antiLeu 3a and Bi. Thus, the cells would appear to be activated (i.e., HLA DR-positive) T cells, lacking the marker for helper T cells.
Cytotoxic Activity and IFN Release. Cell lines established in vitro from HVS-induced marmoset tumors have been shown to have natural killer cell-like activity (30) and to release IFN (31) . Additionally, noncontinuous cultures of owl monkey HVS-induced tumors were found to be cytotoxic for xenogeneic, nonlymphoid target cells and to release IFN (32) . It was of interest, therefore, to determine if the in vitrotransformed cells also possessed these characteristics. Cells from all transformed cell lines had low levels of natural killer cell-like cytotoxicity against MOLT 4 target cells when tested at various times after transformation. Cytotoxicity was consistently enhanced after growth of the cells in IL-2. In a representative experiment (Table 2) , 265(HVS) cells showed low but significant levels of activity when grown without IL-2. Cultivation for 5 days in the presence of either crude or purified IL-2 (both at 300 units/ml) enhanced cytotoxicity 2-to 3-fold. Little activity was observed by any of the lines against K562 target cells except after cultivation in IL-2 (data not shown).
Culture fluids from four of the in vitro-transformed cell lines were tested for the release of IFN at 4 mo after exposure to virus. Cells grown continually without IL-2 were found to release low levels of IFN-10-125 units/ml. However, when grown in the presence of IL-2-containing medium for 1 wk, the level of IFN increased to between 625 and 1325 units/ml. Further experiments with line 265(HVS) showed that IFN levels increased as early as 6 hr after exposure to IL-2. Purified IL-2 was also found to boost IFN release by 265(HVS) cells (250 to 3125 units/ml after 5 days).
The IFN released by the various in vitro-transformed cells appeared to be IFN-y, as it was effective on WISH cells but not on MDBK cells (33) .
Cells grown in the absence of added IL-2 were also tested for the production of IL-2. Culture fluids were concentrated on trimethylsilyl-controlled pore glass beads as described (27) and assayed on an IL-2-sensitive marmoset cell line (14) at a final concentration of 25-fold. Culture fluids from MLA144 cells were used as a positive control. No evidence of IL-2 activity was found in the fluids of any of the HVStransformed cells, although activity in the MLA144 culture fluid was readily demonstrable (data not shown).
Assays for Gibbon Ape Leukemia Virus (GaLV). MLA144 cells were used as the source of IL-2 in this study. These cells are known to be infected with a type C retrovirus, GaLV. It was conceivable that GaLV might have contaminated the IL-2 preparations used and contributed to the cell transformation. Lysates of 107 cells of each of the transformed lines (grown without IL-2), of normal PHA-stimulated owl monkey PBL that had been grown for 3 wk in IL-2, and of MLA144 cells were tested in a broadly reactive competition RIA for primate type C retroviruses. This assay used 1251-labeled CPC-1 p28 and a hyperimmune goat antiserum and can detect the major core antigens of all known primate type C retroviruses (L. Arthur, personal communication). Viral antigen was not detected in lysates of any of the transformed cells nor in that of the normal owl monkey PBL. Antigen was readily detected in the MLA144 cell lysate at a level of 4000 ng/ml. Moreover, concentrated culture fluids from all HVS-transformed cell lines were tested on two separate occasions for retrovirus RNA-dependent DNA polymerase activity with negative results. In addition, DNA samples from all of the transformed cell lines were analyzed for the presence of GaLV sequences by Southern blot hybridization. GaLV sequences were not detected in any of these samples under conditions where GaLV sequences in MLA144 cell DNA were strongly evident. We estimate that one genome copy per cell would have been readily detected.
DISCUSSION
The ability to transform cells with HVS on a regular basis would be of importance in the study of the molecular biology (19, 29) . Viral deletion mutants or temperature-sensitive mutants could conceivably be tested for the ability to transform T cells by using assay procedures described in this report. The transformation protocol described may not be the only or the optimal means of transforming T cells with HVS. However, in contrast to all other procedures that have been tried, it has been very effective in generating continuous lines of HVS-transformed cells. It should now be possible to sort out the steps and components of the procedure that are critical for transformation. Thus, the role of cell activation and use of IL-2 could be carefully evaluated. Because of availability and expense, the IL-2 used in the transformation studies was not purified as was the IL-2 used in selected experiments on cell growth and function. To date, however, IL-2 is the only lymphokine which has been identified conclusively in MLA144 culture fluids. Therefore, while a role for another, as yet unidentified, lymphokine cannot be ruled out, it is likely that the support of T-cell growth and transformation observed in these experiments was due to IL-2. The results on in vitro transformation of owl monkey lymphocytes that we have described are in agreement with preliminary work by others on transformation of marmoset lymphocytes, although it appears that transformation of the marmoset cells required a longer interval after exposure to virus than did the owl monkey lymphocytes (34) . It is apparent from studies both of cell lines established from HVS-induced tumors and from cell lines initiated in vitro that transformation of T cells by HVS results in a decrease in dependency of the cells on IL-2 for growth. Human T lymphocytes transformed in vitro with human T-cell leukemia virus also have shown a decrease in dependency on IL-2 (35, 36) . This raises the possibility that there may be additional parallels between T-cell transformation induced by these two distinct types of viruses. If the behavior of HVS-transformed cells in vitro reflects the behavior of HVS-induced tumor cells in vivo, it would appear that the ability of these cells to replicate in the absence of added IL-2 and their ability to respond to exogenous IL-2 by increased growth and function may be of importance in the pathogenesis of HVS-induced lymphoma.
